Carol Suh
InvestorPartner at ARCH Venture Partners
San Francisco Bay Area
Writes $50K β $150M checks Β· typically $25M
About
Carol Suh is a Partner at ARCH Venture Partners focused on early-stage biotechnology investments. Her background spans both investing and operations, including co-founding Orbital Therapeutics, an RNA medicines company acquired for $1.5B in 2025, and co-founding Neumora Therapeutics, which went public on NASDAQ. She has also invested in HI-Bio, a clinical-stage immunology company acquired by Biogen in 2024, and serves as a founding board member of the Complex Disorders Alliance.
Experience
- ARCH Venture PartnersPartnercurrent2018 β present
- NeumoraCo-Founder and Chief Strategy Officer2019 β 2026San Francisco Bay Area
- Orbital TherapeuticsCo-founder, Board Member2022 β 2025
- HIBioBoard Member2021 β 2024
- Magenta TherapeuticsBusiness Development and Corporate Strategy Associate; Launch Fellow2016 β 2017Cambridge, MA
- Trinity PartnersSenior Associate Consultant2015 β 2016Waltham, MA
- GlaxoSmithKlineR&D Strategy; Innovation Fellow2014Greater Boston
Education
- Stanford University Graduate School of BusinessMaster of Business Administration - MBA
- Yale UniversityMaster of Philosophy (M.Phil.)
- Harvard UniversityBachelor of Arts (B.A.)
- Palos Verdes Peninsula High School
Same school
Also attended Stanford University Graduate School of Business1,147
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew
+ 1,141 more
Also attended Yale University491
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)TinaInvestments & Portfolio Services Team Member at Clear Ventures
+ 485 more
Also attended Harvard University1,170
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,164 more
Also attended Palos Verdes Peninsula High School3
Shared employers
Also worked at ARCH Venture Partners25
Steve GillisManaging Director at ARCH Venture PartnersSean KendallPartner (Europe) at ARCH Venture PartnersCorey RitterPartner at ARCH Venture PartnersLuciana BorioVenture Partner at ARCH Venture PartnersJoseph JeongVenture Partner at ARCH Venture PartnersRichard HeymanVenture Partner at ARCH Venture Partners
+ 19 more
Also worked at HIBio3
Also worked at Magenta Therapeutics2
Colleagues at ARCH Venture Partners
Ari Nowacek
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
David Moore
Senior Partner at ARCH Venture Partners
George Scangos
Venture Partner at ARCH Venture Partners
Inca Coman
Venture Partner at ARCH Venture Partners
Network5
Ari Nowacek
Partner at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
Inca Dieterich
Venture Partner at ARCH Venture Partners
Jake Bauer
Venture Partner at ARCH Venture Partners
Jay Kocherlakota
Senior Associate at ARCH Venture Partners
Investors connected to Carol in public investor directories β a warm-intro map.



































